Department of Medical Statistics, Toho University, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan.
Department of Environmental and Occupational Health, Toho University, Tokyo, Japan.
J Gastroenterol. 2019 Dec;54(12):1070-1077. doi: 10.1007/s00535-019-01603-8. Epub 2019 Jul 15.
BACKGROUND: Almost a quarter century has passed since the first nationwide survey on ulcerative colitis (UC) and Crohn's disease (CD) was conducted in Japan. In this study, we used a nationwide survey to estimate the number of patients and prevalence of these diseases in Japan in 2014. METHODS: We conducted a mail-based survey targeting hospitals to estimate the annual numbers of patients with UC and CD in 2014. Respondents were asked to report the numbers of patients who met specific diagnostic criteria for these two conditions. A stratified random sampling method was used, and a total of 3712 departments (internal medicine, surgery, pediatrics, and pediatric surgery) were selected for analysis. The overall and sex-specific annual numbers of UC and CD patients were estimated. The corresponding prevalence rates per 100,000 population were calculated by dividing the number of patients with each disease by the mid-year population of Japan in 2014. RESULTS: The overall survey response rate was 56.7% (2016 departments). The estimated numbers of patients with UC and CD were 219,685 (95% confidence interval: 183,968-255,403) and 70,700 (56,702-84,699), respectively. The annual prevalence rates of UC and CD per 100,000 population were 172.9 (men: 192.3; women: 154.5) and 55.6 (men: 79.5; women: 33.1), respectively. These numbers are almost tenfold increase in comparing the previous survey (22,300 in UC and 7,400 in CD). The male-to-female ratios were 1.24 for UC and 2.40 for CD, and the UC-to-CD ratio was 3.11. CONCLUSIONS: The prevalence of UC and CD in Japan has risen substantially over the past two decades, and their disease burden requires further examination.
背景:自日本首次进行全国性溃疡性结肠炎(UC)和克罗恩病(CD)调查以来,已经过去了将近四分之一个世纪。在本研究中,我们使用全国性调查来估计 2014 年日本这些疾病的患者人数和患病率。
方法:我们通过邮寄调查针对医院来估计 2014 年 UC 和 CD 的年度患者人数。调查对象被要求报告符合这两种疾病特定诊断标准的患者人数。采用分层随机抽样方法,共选择了 3712 个科室(内科、外科、儿科和小儿外科)进行分析。估计了 UC 和 CD 患者的总体和性别特异性年度人数。通过将每种疾病的患者人数除以 2014 年日本年中的人口数,计算出每 10 万人的相应患病率。
结果:总体调查应答率为 56.7%(2016 个科室)。估计的 UC 和 CD 患者人数分别为 219685(95%置信区间:183968-255403)和 70700(56702-84699)。每 10 万人的 UC 和 CD 年患病率分别为 172.9(男性:192.3;女性:154.5)和 55.6(男性:79.5;女性:33.1)。与前一次调查相比,这些数字几乎增加了十倍(UC 为 22300,CD 为 7400)。男女比例分别为 UC 的 1.24 和 CD 的 2.40,UC 与 CD 的比例为 3.11。
结论:过去二十年中,日本 UC 和 CD 的患病率显著上升,其疾病负担需要进一步研究。
Clin Gastroenterol Hepatol. 2017-6
Intractable Rare Dis Res. 2025-8-31
Pediatr Gastroenterol Hepatol Nutr. 2025-5
BMC Musculoskelet Disord. 2018-7-27
J Gastroenterol. 2018-2-10
Best Pract Res Clin Gastroenterol. 2014-5-4
Gastroenterology. 2011-10-14
J Dig Dis. 2010-4
Clin Orthop Relat Res. 2010-3-12
J Gastroenterol. 2009